Bleeding Pattern Study

NCT00302666 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1315

Enrollment

INDUSTRY

Sponsor class

Conditions

Oral Contraceptive

Interventions

DRUG: Valette (Dienogest/EE30, BAY86-5038)
DRUG: Valette (Dienogest/EE30, BAY86-5038)

Sponsor

Bayer